NEW2026 · Text us +1 272-529-4722
Hydroxychloroquine is a prescription antimalarial and immunomodulatory medication used to treat malaria and chronic autoimmune conditions such as rheumatoid arthritis and systemic lupus erythematosus. In autoimmune diseases, hydroxychloroquine helps reduce inflammation, joint pain, skin manifestations, and disease flares by modulating immune system activity rather than broadly suppressing immune function. Hydroxychloroquine is generally well tolerated when used as directed, though ongoing clinical monitoring is recommended during prolonged use.
Reviewed by:
Dr. Steve Malen, PharmD
Dr. Steven Blikstein, PharmD
Strength
How would you like to get this medication?
Choose a strength and quantity to continue.
Hydroxychloroquine is a prescription antimalarial and immunomodulatory medication used to treat malaria and chronic autoimmune conditions such as rheumatoid arthritis and systemic lupus erythematosus. In autoimmune diseases, hydroxychloroquine helps reduce inflammation, joint pain, skin manifestations, and disease flares by modulating immune system activity rather than broadly suppressing immune function. Hydroxychloroquine is generally well tolerated when used as directed, though ongoing clinical monitoring is recommended during prolonged use.
Complete a health screening
A short questionnaire about your health history and current symptoms — takes about 2 minutes.
Provider reviews your answers
A licensed provider reviews your screening answers, typically within 24 hours.
Prescription fulfilled
If approved, your Rx is sent to Invictus Pharmacy and you're notified by text or email. Free nationwide shipping.
Important safety information
Certain conditions make Plaquenil unsafe for use, and recognizing these contraindications is crucial to preventing harm and ensuring appropriate patient selection.
Understanding these contraindications and precautions enables healthcare providers to determine whether Plaquenil is suitable for each patient and to ensure ongoing monitoring throughout therapy.
Amitriptyline is a prescription antidepressant used to treat major depressive disorder (MDD) and, in some cases, chronic pain, migraine prevention, and sleep disturbances. As a tricyclic antidepressant (TCA), it increases levels of certain neurotransmitters in the brain, such as serotonin and norepinephrine. Amitriptyline helps improve mood, relieve anxiety and tension, and promote better sleep. It is available by prescription only and should be taken exactly as directed by a healthcare provider.
Intrathecal baclofen is a prescription muscle relaxant that reduces spasticity, stiffness, and muscle spasms caused by conditions such as multiple sclerosis, spinal cord injury, or cerebral palsy. It acts on the central nervous system to decrease excessive muscle contractions and is available in oral or intrathecal forms, depending on patient needs and symptom severity. Abruptly stopping treatment can cause severe withdrawal symptoms, so dosage changes must be made gradually under a physician’s direction.
A COX-2 inhibitor NSAID for arthritis and pain relief, with fewer stomach side effects than traditional NSAIDs.
Video visit required
Cyclobenzaprine is a prescription muscle relaxant used to relieve muscle spasms and pain from acute musculoskeletal conditions such as strains or sprains. Acting on the central nervous system, it reduces muscle tension and improves mobility. Typically prescribed for short-term use, Cyclobenzaprine is often combined with rest and physical therapy for optimal recovery. Patients should avoid driving or operating machinery during the initial treatment period. Alcohol and other sedatives should be avoided, as they can increase drowsiness and side effects.
An NSAID used to relieve pain, swelling, and inflammation from arthritis and joint or muscle injuries.
Video visit required
Dihydroergotamine mesylate is a prescription ergot alkaloid used to treat acute migraine attacks, with or without aura, in adults. It works by constricting blood vessels around the brain and reducing inflammation of nerve pathways that cause migraine pain, nausea, and light or sound sensitivity. Available as a nasal spray or injection, it is used at migraine onset rather than for prevention. Dihydroergotamine mesylate must be used only as directed at the start of a migraine, not daily, to avoid rebound headaches. It should not be used within 24 hours of triptans or other ergot drugs and is contraindicated in patients with certain heart or liver conditions.
Hydroxychloroquine, the active ingredient in Plaquenil, is an antimalarial drug. While its initial use was to combat malaria, its ability to modulate the immune response has been pivotal in treating autoimmune conditions.
As a disease-modifying antirheumatic drug (DMARD), hydroxychloroquine helps regulate the immune system without severely suppressing it, making it a valuable treatment option for conditions such as rheumatoid arthritis and lupus.
The mechanism by which hydroxychloroquine exerts its effects includes blocking the signaling pathways that trigger immune cell activation, ultimately reducing inflammation and slowing disease progression.
Note: This medication’s generic and brand-name formulations are used interchangeably throughout this article.
Plaquenil is a well-recognized medication used predominantly for its effects on the immune system. It is a brand name for hydroxychloroquine, a medication that has garnered attention for its versatility in treating various conditions.
Primarily, Plaquenil is used to manage autoimmune diseases, in which the immune system attacks the body’s own tissues, causing inflammation and damage.
Plaquenil is used to treat several conditions due to its anti-inflammatory and immune-regulating properties. These uses range from officially approved indications to off-label applications that further explore its potential benefits.
The versatility of Plaquenil in managing both primary and off-label conditions stems from its ability to target the immune system without causing broad immunosuppression. This makes it suitable for long-term management of diseases with immune dysregulation.
Understanding how Plaquenil operates provides insight into its effectiveness in treating various conditions, particularly those that affect the immune system.
Plaquenil functions by altering the behavior of immune cells, decreasing inflammation and symptoms in autoimmune diseases. Specifically, it accumulates in lysosomes and increases their pH, interfering with the normal processing and presentation of antigens required for immune cell communication.
This helps reduce the inflammatory response caused by overactive immune cells, dampening the symptoms of autoimmune diseases.
Plaquenil is well absorbed after oral administration and is widely distributed throughout the body, reaching the liver, spleen, kidneys, and eyes.
One of its defining characteristics is its long half-life, allowing for sustained action over extended periods, which is beneficial in chronic disease states where consistent therapeutic levels are required to maintain symptom control.
This pharmacokinetic profile supports less frequent dosing schedules, promoting adherence to treatment and reducing the risk of side effects associated with peak plasma concentrations.
The effectiveness of Plaquenil is closely linked to adhering to recommended dosages and understanding administration guidelines to minimize potential adverse effects.
Plaquenil should be taken with food or a glass of milk to prevent gastrointestinal discomfort. Given its potential for causing retinal toxicity, it is crucial to undergo regular eye examinations to detect early signs of retinal damage.
Moreover, patients are advised to follow a consistent dosing schedule to maintain stable blood levels and to adhere to regular follow-ups to monitor long-term safety and effectiveness.
While Plaquenil is generally well-tolerated, it can cause side effects ranging from mild to severe. Understanding these possibilities allows patients and providers to make informed decisions and monitor appropriately during treatment.
Patients taking Plaquenil should be educated about these side effects and advised to contact their healthcare provider if they experience unusual symptoms. Early detection and management of side effects can prevent long-term complications.
Medication interactions are an important consideration with Plaquenil, as they may influence therapeutic outcomes or increase the risk of side effects. Reviewing all concurrent treatments helps ensure safe and effective use.
By recognizing and managing these interactions, patients can minimize risk while maximizing Plaquenil’s effectiveness.
Administration & Dosage
Plaquenil is typically administered orally as tablets. Adhering to your healthcare provider's instructions regarding the dosage and frequency of intake is crucial for effectiveness. It is usually recommended to take it with food or milk to minimize stomach upset.
The lowest available dose of Plaquenil is 200 mg. Your healthcare provider will determine the appropriate dosage based on your specific medical condition and response to treatment, making adjustments as necessary over time.
For most patients, Plaquenil requires several weeks to months to exhibit its full therapeutic effects. Regular monitoring with your healthcare provider is essential for evaluating the medication's effectiveness and making any necessary adjustments in dosage or treatment protocols.
Taking Plaquenil at night is appropriate if it aligns with your prescribed dosing schedule. Consistency in timing helps maintain stable drug levels in your body, enhancing the medication’s therapeutic effects and minimizing potential side effects.
Plaquenil has a long half-life, so it remains in the system for several weeks. Complete elimination may take months after discontinuing the medication. This extended presence aids in its efficacy for chronic conditions but requires monitoring for side effects.
Uses & Mechanism of Action
Plaquenil is predominantly used to manage autoimmune diseases such as lupus and rheumatoid arthritis. It is also employed in the prevention and treatment of malaria. Its therapeutic range illustrates its versatility in managing complex immune responses and infections.
Plaquenil functions by modulating the immune system, which is advantageous in controlling autoimmune diseases. It reduces inflammatory response and can prevent disease flares, offering relief from symptoms such as pain and swelling associated with these conditions.
In the treatment of lupus, Plaquenil mitigates immune system overactivity, helping reduce symptoms such as joint pain, fatigue, and the frequency of disease flares. This action supports long-term disease management and improves the patient's quality of life.
Plaquenil is categorized as a disease-modifying antirheumatic drug (DMARD). It plays a vital role in slowing the progression of autoimmune diseases, decreasing their overall activity and potential impact on bodily functions over time.
While Plaquenil possesses immunomodulatory effects, it is not a classic immunosuppressant. Instead, it finely tunes immune response, enhancing its utility in treating autoimmune conditions without the broad suppression associated with traditional immunosuppressive therapies.
Side Effects & Safety
Common side effects of Plaquenil include headaches, dizziness, and gastrointestinal issues such as diarrhea or constipation. Skin rashes may also occur. Serious side effects can affect vision, necessitating regular eye examinations while on this medication.
Weight gain is not commonly associated with Plaquenil, though some patients may notice weight fluctuations. These changes could be related to fluid retention or lifestyle factors, rather than direct drug effects. Discuss concerns with your healthcare provider.
Hair loss is a possible but uncommon side effect of Plaquenil. Patients experiencing significant hair thinning should seek medical advice, as the condition may necessitate adjustments in medication or additional interventions to address underlying causes.
Plaquenil can cause fatigue or drowsiness in some individuals, though these effects are typically mild. Patients who experience severe sleepiness should consult their healthcare provider to evaluate the cause and consider alternative treatment strategies.
The safety of Plaquenil in pregnancy is not fully established. It should be used only when the potential benefits outweigh the potential risks. Pregnant individuals should consult with their healthcare provider to assess the medication's appropriateness for their situation.
Interactions & Contraindications
Ibuprofen can generally be taken with Plaquenil. However, it is wise to consult a healthcare provider before combining these medications, as individual factors may affect their safety and effectiveness when used concurrently.
While taking Plaquenil, patients should avoid alcohol and excessive sun exposure to minimize potential adverse effects. Interactions with certain over-the-counter drugs should also be considered. Discuss all substances with your healthcare provider to ensure safety.
Some antibiotics can be safely taken with Plaquenil, though not all. It is essential to consult your healthcare provider before combining these medications to confirm compatibility and prevent adverse reactions due to drug interactions.
Plaquenil should not be combined with medications that prolong the QT interval or compromise liver function. A thorough review of all your current medications with your healthcare provider is crucial to prevent dangerous interactions.
Abruptly stopping Plaquenil is discouraged due to the risk of symptom flare-ups. It is essential to follow your healthcare provider's guidance when discontinuing treatment to manage potential rebound effects or exacerbation of disease activity.
Generic & Alternatives
Plaquenil and hydroxychloroquine are synonymous. Plaquenil is the branded version of hydroxychloroquine sulfate. Both contain the same active ingredient and are used interchangeably to manage autoimmune diseases and malaria.
The generic name for Plaquenil is hydroxychloroquine sulfate. Identifying medications by their generic names can facilitate understanding and improve communication with healthcare providers regarding treatment plans and medication equivalence.
Alternatives to Plaquenil for lupus may include methotrexate, corticosteroids, or other immunosuppressive agents. These options vary based on individual patient needs and should be thoroughly discussed with a healthcare provider to tailor treatment effectively.
Plaquenil is not a steroid. Instead, it is classified as an antimalarial and has immunomodulatory properties. This makes it effective in treating autoimmune diseases like lupus, without the broad immune suppression linked with steroids.
Plaquenil is not considered high-risk but requires careful monitoring due to potential side effects, particularly affecting vision and heart function. Regular medical check-ups are imperative to ensure patient safety and optimize therapeutic outcomes.